We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
UCB, a global pharmaceutical company, has joined forces with Parkinson's UK, and the Parkinson's Foundation in the US, to establish a Patient Engagement Council for Parkinson's Research.
Date
We've launched a new report, Nobody really knows us – the state of health and social care for people with Parkinson's-related dementia.
Date
We've developed an interactive communications toolkit to help researchers in all areas of health research to keep in touch with their participants. It is supported by the Health Research Authority (HRA) as part of the Make It Public strategy.
Date
Next has released a new exclusive range in collaboration with internationally-renowned artist Alex Echo, who was diagnosed with Parkinson's in early 2020.
Date
Not enough people understand what it's like to live with Parkinson's. Together, we can change that.
Date
We've invested a further £490,000 to support the development of drugs to protect mitochondria and treat Parkinson's.
Date
Results show that atomoxetine, a drug used to treat attention deficit hyperactivity disorder (ADHD), could improve thinking and impulsiveness in Parkinson's.
Date
Researchers in the United States have shown that a compound found in fruit - farnesol - has the potential to play a protective role to dopamine-producing brain cells.
Date
Caroline Rassell has been appointed as our new Chief Executive. She brings 20 years of board experience in healthcare and government roles.
Date
Broadcaster Jeremy Paxman has announced that he was recently diagnosed with Parkinson's, and that his symptoms are currently mild.